TOP ONCOLOGY CRO
EXPERTS IN CLINICAL ONCOLOGY
QUALITY ONCOLOGY TRIAL MONITORING
home blog news careers français contact
QUALITY ONCOLOGY TRIAL MANAGEMENT


Why so many US oncology drug developers have enhanced their clinical trial performance by leveraging Canada for successful study expansion.


The Reverse Feasibility Program™

A Novel CRO Approach to Site Selection
& Patient Recruitment

Reverse Feasibility Program for 50% faster site start-up.A revolutionary approach to feasibility assessment that accelerates study start-up by matching your protocol with the current study needs of motivated and pre-qualified North American sites.

How it works...


Oncology Clinical Trial News

Scimega launches Canadian expansion of a Phase I/II, Multicenter,Pharmacokinetic Guided Dose-Escalation and Dose-Confirmation Study of a Cytidine Deaminase Inhibitor (CDAi) in Subjects with Myelodysplastic Syndromes (MDS).

Scimega launches Canadian expansion of a Phase I/II, Multicenter Study to Evaluate the Safety and Efficacy of a novel, rationally designed, oncology drug candidate in Combination with nab-Paclitaxel (Abraxane®) and Gemcitabine in Patients with Metastatic Pancreatic Cancer.

Scimega launches Canadian expansion of an ongoing Phase 1 / 2 Study of an HSP90 Inhibitor Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer.

Scimega launches Canadian expansion of an ongoing Phase 1b, open-label study to assess the safety and tolerability of an orally active, reversible and selective HER2 inhibitor combined with trastuzumab emtansine (TDM1) in HER2+metastatic breast cancer..

See all news...

Upcoming Scimega Events

Clinical Operations in Oncology Trials – West Coast

April 15-16, 2015 in Burlingame, CA

AACR Annual Meeting (American Association for Cancer Research)

April 18-22, 2015 in Philadelphia

Partnerships in Clinical Trials

April 21-24, 2015 in Boston

See all upcoming events...


Latest Podcast

Busting Myths about Canadian Regulatory Review

An interview with Susanne Picard, Founder & President of SPharm
Listen...



Copyright © Scimega Research Inc. 2014. All rights reserved.
Privacy Policy

Oncology CRO   Clinical Trial Monitoring   Clinical Trial Management   Oncology Community